ISPOR 2026 Home
  • About
    • News Center
  • Program
    • Program
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Plenary Sessions
  • Exhibits & Sponsorship
    • Exhibitor Directory
    • Sponsors
    • Media Partners
  • Photo Gallery
large-circle

ISPOR 2026

Sunday, May 17 - Wednesday, May 20

  • Home
  • Events
  • Past Conferences
  • ISPOR 2026
  • Program
  • Program
  • Presentation
  • REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY

    Mar 18, 2026, 21:38 PM
  • PHYSICIAN-LED CHART ABSTRACTION (PLCA) IN ONCOLOGY: ADVANCING FDA FIT-FOR-USE REAL-WORLD DATA FOR HEOR DECISION-MAKING

    Mar 18, 2026, 21:38 PM
  • PERFORMANCE OF ADAPTIVE SMART TAGS IN NESTED KNOWLEDGE FOR AUTOMATED EXTRACTION OF STUDY CHARACTERISTICS

    Mar 18, 2026, 21:38 PM
  • HEALTHCARE EXPENDITURE AMONG INDIVIDUALS LIVING WITH ALZHEIMER’S DISEASE: A JAPANESE PUBLIC HEALTHCARE PERSPECTIVE

    Mar 18, 2026, 21:38 PM
  • HOSPITAL BUDGET IMPACT MODEL OF TV-46000, A LONG-ACTING SUBCUTANEOUS FORMULATION OF RISPERIDONE, VERSUS ONCE-MONTHLY PALIPERIDONE PALMITATE IN ADULTS WITH SCHIZOPHRENIA IN THE UNITED STATES

    Mar 18, 2026, 21:38 PM
  • ENHANCING CLINICAL TRIAL ELIGIBILITY CRITERIA DESIGN WITH GENERATIVE ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING

    Mar 18, 2026, 21:38 PM
  • UNDERSTANDING THE GLOBAL ECONOMIC BURDEN OF HEPATITIS DELTA VIRUS: A SYSTEMATIC LITERATURE REVIEW

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD MULTIPLE MYELOMA TREATMENT RESPONSES: EVALUATION OF FRONTLINE REGIMENS IN MELDTM LINKED MEDICARE, LABORATORY AND ELECTRONIC MEDICAL RECORDS...

    Mar 18, 2026, 21:38 PM
  • COMPARATIVE ANALYSIS OF RISK FACTORS AND SHORT-TERM OUTCOMES AFTER PRIMARY PCI IN PRE- AND POST-MENOPAUSAL WOMEN WITH STEMI EXPERIENCE FROM LMIC

    Mar 18, 2026, 21:38 PM
  • SOCIODEMOGRAPHIC AND CLINICAL FACTORS ASSOCIATED WITH TIME TO TREATMENT INITIATION AND CARE PATHWAYS IN NON-METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN COLOMBIA: A REAL-WORLD EVIDENCE STUDY

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD CONCORDANCE WITH THE FRAMINGHAM STROKE RISK MODEL IN ATRIAL FIBRILLATION AND IDENTIFICATION OF ADDITIONAL SIGNIFICANT FEATURES

    Mar 18, 2026, 21:38 PM
  • PREVALENCE OF CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME AMONG OLDER WOMEN WITH BREAST CANCER IN THE 2011-2021 SEER-MEDICARE DATA

    Mar 18, 2026, 21:38 PM
  • A UNITED STATES BUDGET IMPACT ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN THE TREATMENT OF INADEQUATELY CONTROLLED ASTHMA

    Mar 18, 2026, 21:38 PM
  • PSYCHOSOCIAL AND SUPPORTIVE INTERVENTIONS FOR CAREGIVERS OF INDIVIDUALS WITH DEMENTIA: A SYSTEMATIC REVIEW

    Mar 18, 2026, 21:38 PM
  • DEVELOPMENT OF A MULTI-AGENT "DEEP" AI SYSTEM FOR HEOR EVIDENCE AND INTELLIGENCE GENERATION

    Mar 18, 2026, 21:38 PM
  • EVALUATING THE PERFORMANCE OF A GENERATIVE ARTIFICIAL INTELLIGENCE CHATBOT FOR ASSESSING SYSTEMATIC LITERATURE REVIEWS USING THE PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES 2020 CHECKLIST

    Mar 18, 2026, 21:38 PM
  • SOCIOECONOMIC BURDEN OF DRY EYE DISEASE IN THE UNITED STATES: REAL-WORLD EVIDENCE FROM THE ADELPHI DED DISEASE SPECIFIC PROGRAMME

    Mar 18, 2026, 21:38 PM
  • INCIDENCE AND COSTS OF SECONDARY STROKE EVENTS IN PATIENTS WITH ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK OF NON-CARDIOEMBOLIC ORIGIN

    Mar 18, 2026, 21:38 PM
  • FROM EVIDENCE TO PRICE: EMBEDDING PRICING STRATEGY IN EARLY MARKET ACCESS PLANNING

    Mar 18, 2026, 21:38 PM
  • REAL-WORLD EVIDENCE METHODOLOGY FOR ECONOMIC EVALUATION OF CLINICAL AI: COST-EFFECTIVENESS OF AN IMAGING ALGORITHM FOR INCIDENTAL DETECTION OF EMPHYSEMA

    Mar 18, 2026, 21:38 PM
  • «
  • 21
  • 22
  • 23
  • 24
  • 25 (current)
  • 26
  • 27
  • 28
  • 29
  • 30
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group